<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baltussen LL</submitter><funding>Cancer Research UK</funding><funding>The Francis Crick Institute</funding><funding>Medical Research Council</funding><funding>NIMH NIH HHS</funding><funding>National Institute of Mental Health</funding><funding>Wellcome Trust</funding><funding>International Foundation for CDKL5 Research</funding><pagination>e99763</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6293278</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(24)</volume><pubmed_abstract>Loss-of-function mutations in CDKL5 kinase cause severe neurodevelopmental delay and early-onset seizures. Identification of CDKL5 substrates is key to understanding its function. Using chemical genetics, we found that CDKL5 phosphorylates three microtubule-associated proteins: MAP1S, EB2 and ARHGEF2, and determined the phosphorylation sites. Substrate phosphorylations are greatly reduced in CDKL5 knockout mice, verifying these as physiological substrates. In CDKL5 knockout mouse neurons, dendritic microtubules have longer EB3-labelled plus-end growth duration and these altered dynamics are rescued by reduction of MAP1S levels through shRNA expression, indicating that CDKL5 regulates microtubule dynamics via phosphorylation of MAP1S. We show that phosphorylation by CDKL5 is required for MA</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics.</pubmed_title><pmcid>PMC6293278</pmcid><funding_grant_id>20152375</funding_grant_id><funding_grant_id>F31 MH010771</funding_grant_id><funding_grant_id>R21MH10771</funding_grant_id><funding_grant_id>FC001003</funding_grant_id><funding_grant_id>FC001201</funding_grant_id><funding_grant_id>10011</funding_grant_id><funding_grant_id>10015</funding_grant_id><funding_grant_id>1362387</funding_grant_id><funding_grant_id>10201</funding_grant_id><pubmed_authors>Ultanir SK</pubmed_authors><pubmed_authors>Claxton S</pubmed_authors><pubmed_authors>Muotri AR</pubmed_authors><pubmed_authors>Snijders AP</pubmed_authors><pubmed_authors>Moeskops M</pubmed_authors><pubmed_authors>Flynn HR</pubmed_authors><pubmed_authors>Christodoulou E</pubmed_authors><pubmed_authors>Baltussen LL</pubmed_authors><pubmed_authors>Negraes PD</pubmed_authors><pubmed_authors>Silvestre M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics.</name><description>Loss-of-function mutations in CDKL5 kinase cause severe neurodevelopmental delay and early-onset seizures. Identification of CDKL5 substrates is key to understanding its function. Using chemical genetics, we found that CDKL5 phosphorylates three microtubule-associated proteins: MAP1S, EB2 and ARHGEF2, and determined the phosphorylation sites. Substrate phosphorylations are greatly reduced in CDKL5 knockout mice, verifying these as physiological substrates. In CDKL5 knockout mouse neurons, dendritic microtubules have longer EB3-labelled plus-end growth duration and these altered dynamics are rescued by reduction of MAP1S levels through shRNA expression, indicating that CDKL5 regulates microtubule dynamics via phosphorylation of MAP1S. We show that phosphorylation by CDKL5 is required for MA</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2026-05-06T06:15:03.111Z</modification><creation>2019-03-27T00:12:31Z</creation></dates><accession>S-EPMC6293278</accession><cross_references><pubmed>30266824</pubmed><doi>10.15252/embj.201899763</doi></cross_references></HashMap>